ODDERSHEDE, Jonas K.; MEKLENBORG, Ida K.; BASTHOLT, Lars; GULDBRANDT, Louise M.; SCHMIDT, Henrik; FRIIS, Rasmus B. Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility. Acta Oncologica, [S. l.], v. 64, p. 507–515, 2025. DOI: 10.2340/1651-226X.2025.42567. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/42567. Acesso em: 26 may. 2026.